REPORTS OF SUSPECTED VIVELLE-DOT SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Vivelle-DOT. The information is not vetted and should not be considered as verified clinical evidence.
Possible Vivelle-DOT side effects / adverse reactions in 63 year old female
Reported by a consumer/non-health professional from United States on 2011-10-21
Patient: 63 year old female
Reactions: Eye Irritation, Urticaria, Petechiae, Pyrexia, Erythema, Arthropathy, Lymph Node Pain, Feeling Hot, Oedema Mucosal, Musculoskeletal Stiffness, Oropharyngeal Blistering, Blister, Cough, Pain in Extremity, Rash, Arthralgia, Dysphonia, Ocular Hyperaemia, Genital Swelling
Suspect drug(s):
Plaquenil
Administration route: Oral
Indication: Autoimmune Disorder
Mobic
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Neurontin
Administration route: Oral
Indication: Arthralgia
Immune Globulin Intravenous (Human)
Indication: Combined Immunodeficiency
Start date: 2010-06-01
End date: 2011-10-01
Vivelle-DOT
Indication: Hormone Replacement Therapy
Klonopin
Administration route: Oral
Indication: Restless Legs Syndrome
Gammagard Liquid
Indication: Combined Immunodeficiency
Start date: 2011-10-02
End date: 2011-10-06
Possible Vivelle-DOT side effects / adverse reactions in 48 year old female
Reported by a physician from United States on 2011-10-25
Patient: 48 year old female
Reactions: Small Intestinal Obstruction, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Vivelle-DOT
Possible Vivelle-DOT side effects / adverse reactions in 60 year old female
Reported by a consumer/non-health professional from United States on 2011-11-18
Patient: 60 year old female weighing 61.7 kg (135.7 pounds)
Reactions: Aphagia, Asthma, Nightmare, Increased Upper Airway Secretion, Upper-Airway Cough Syndrome, Upper Respiratory Tract Inflammation, Hot Flush, Insomnia, DRY Throat, DRY Mouth, Nasal Dryness, Cough, Aphonia
Suspect drug(s):
Climara
Dosage: 0375 mg, unk
Indication: Hysterectomy
Start date: 2011-01-01
End date: 2011-10-03
Climara
Dosage: 0.375 mg, unk
Indication: Autonomic Nervous System Imbalance
Start date: 2000-01-01
Vivelle-DOT
Dosage: 0.275 mg, q2wk
Indication: Hysterectomy
Start date: 2011-01-01
Other drugs received by patient: Losartan
|